Our Approach
Why Longevity, Why Now
The longevity economy is one of the largest structural opportunities of the next two decades, and it is still early.
The numbers
$8T
Longevity economy projected by 2030
$8.49B
Private longevity investment across 325 deals in the most recent year
$85B
Anti-aging and longevity therapeutics market in 2025, heading toward $120B by 2030
2x
Growth of the world’s 65+ population by 2050
How we are different
How We Are Different
Traditional Regional Model
Sarmad Ventures
Structure
Grant-based, philanthropic
For-profit, equity-owning
Focus
Funds scientific research
Builds and owns companies
Capital model
Donor-dependent
Self-sustaining, multiple revenue lines
Regional scope
Single-country
GCC-wide and global
Where others fund the science, we build the businesses.